Macovan

Cefaclor, the active ingredient in Macovan, is a second‑generation cephalosporin presented as an oral tablet for oral use. It treats bacterial infections of the respiratory tract, middle ear, skin and urinary system in adults and children when prescribed by a healthcare professional.

GNH USA supplies Macovan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Customers benefit from consistent batch release and comprehensive regulatory documentation.

Cefaclor is a second‑generation cephalosporin antibiotic that interferes with bacterial cell‑wall synthesis, making it effective for several common infections.

- Upper respiratory tract infections: Reduces bacterial load and alleviates symptoms such as cough, sore throat and nasal discharge. - Otitis media: Eradicates the causative bacteria in middle‑ear infections, improving pain and hearing. - Skin and soft tissue infections: Controls bacterial proliferation in cellulitis, impetigo and wound infections. - Urinary tract infections: Clears pathogenic organisms from the urinary tract, relieving dysuria and frequency.

Cefaclor may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, occasionally watery. - Abdominal pain: cramping or discomfort. - Vomiting: occasional emesis. - Rash: mild skin redness or itching. - Headache: transient head discomfort.

Serious or Rare Side Effects: - Clostridioides difficile‑associated diarrhea: severe colitis requiring medical attention. - Anaphylaxis: life‑threatening allergic reaction with airway compromise. - Stevens‑Johnson syndrome: severe skin and mucosal blistering. - Serum sickness: fever, arthralgia and rash. - Hemolytic anemia: destruction of red blood cells. - Hepatic dysfunction: elevated liver enzymes or jaundice.

Before prescribing Cefaclor, clinicians should consider patient‑specific factors and monitor for potential complications.

- Assess renal function: adjust dose in patients with impaired renal clearance. - Monitor for hypersensitivity: discontinue immediately if rash, urticaria or anaphylaxis develop. - Avoid use in patients with known cephalosporin or severe penicillin allergy. - Use with caution in pregnancy or breastfeeding: weigh maternal benefit against potential fetal risk. - Counsel patients on possible gastrointestinal upset and advise adequate hydration. - Store at room temperature: keep in the original pack, protect from moisture and heat.

Cefaclor can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Probenecid: may increase cefaclor plasma concentrations, raising toxicity risk. - Oral anticoagulants (e.g., warfarin): can enhance anticoagulant effect and bleeding. - Live bacterial vaccines: antibiotic may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Metformin: elevated risk of lactic acidosis in renal impairment. - Oral contraceptives: possible reduction in hormonal efficacy. - Diuretics: may exacerbate electrolyte disturbances. - Allopurinol: increased incidence of rash when combined.